• Publications
  • Influence
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous systemExpand
  • 7,465
  • 350
  • PDF
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
New diagnostic criteria for multiple sclerosis integrating magnetic resonance image assessment with clinical and other paraclinical methods were introduced in 2001. The “McDonald Criteria” have beenExpand
  • 4,634
  • 203
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
BACKGROUND Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is commonly misdiagnosed as multipleExpand
  • 2,397
  • 186
The clinical course of neuromyelitis optica (Devic’s syndrome)
Objectives: To evaluate the spectrum of neuromyelitis optica (NMO), including characteristics of the index events (optic neuritis [ON]) and myelitis), neuroimaging, CSF, and serologic studies, and toExpand
  • 1,465
  • 142
The spectrum of neuromyelitis optica
Neuromyelitis optica (also known as Devic's disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially affects the optic nerve and spinal cord.Expand
  • 1,645
  • 133
  • PDF
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). Prior NMO diagnosticExpand
  • 1,472
  • 116
  • PDF
Revised diagnostic criteria for neuromyelitis optica
Background: The authors previously proposed diagnostic criteria for neuromyelitis optica (NMO) that facilitate its distinction from prototypic multiple sclerosis (MS). However, some patients withExpand
  • 1,555
  • 99
Revised diagnostic criteria for neuromyelitis optica.
BACKGROUND The authors previously proposed diagnostic criteria for neuromyelitis optica (NMO) that facilitate its distinction from prototypic multiple sclerosis (MS). However, some patients withExpand
  • 950
  • 90
  • PDF
Multiple sclerosis.
  • 710
  • 84
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.
The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New therapies appear to favourably impact theExpand
  • 1,021
  • 50
  • PDF